|
|
|
|
| LEADER |
00000cam a22000007a 4500 |
| 001 |
SCIDIR_on1400972942 |
| 003 |
OCoLC |
| 005 |
20231120010755.0 |
| 006 |
m o d |
| 007 |
cr un|---aucuu |
| 008 |
230930s2023 xx o 000 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|c YDX
|d SFB
|d OPELS
|d OCLCO
|
| 020 |
|
|
|a 9780443236129
|q (electronic bk.)
|
| 020 |
|
|
|a 0443236127
|q (electronic bk.)
|
| 020 |
|
|
|z 9780443236112
|
| 020 |
|
|
|z 0443236119
|
| 035 |
|
|
|a (OCoLC)1400972942
|
| 050 |
|
4 |
|a RC376.5
|
| 082 |
0 |
4 |
|a 616.83
|
| 245 |
0 |
0 |
|a Movement disorders emergencies.
|
| 260 |
|
|
|a [S.l.] :
|b Academic Press,
|c 2023.
|
| 300 |
|
|
|a 1 online resource.
|
| 490 |
0 |
|
|a International review of movement disorders ;
|v 6
|
| 505 |
0 |
|
|a Intro -- Movement Disorders Emergencies -- Copyright -- Contents -- Contributors -- Preface -- Chapter One: Management of acute non-motor symptoms of Parkinson�s disease -- 1. Introduction -- 2. Park-depression/anxiety -- 2.1. Introduction to the park-depression/anxiety subtype -- 2.1.1. Acute emergencies within the park-depression/anxiety subtype -- 2.1.1.1. Acute depression -- 2.1.1.2. Dopamine agonist withdrawal syndrome -- 3. Park-sleep -- 3.1. Introduction to the park-sleep subtype -- 3.1.1. Acute emergencies within the park-sleep subtype -- 3.1.1.1. Sudden onset of sleep -- 4. Park-autonomic -- 4.1. Introduction to the park-autonomic subtype -- 4.1.1. Emergencies within the park-autonomic subtype -- 4.1.1.1. Acute constipation -- 5. Acute psychosis and acute delirium -- 5.1. Acute psychosis -- 5.2. Acute delirium -- 6. Parkinsonism hyperpyrexia syndrome and neuroleptic malignant syndrome -- 7. Conclusion -- References -- Further reading -- Chapter Two: Movement disorders emergencies in metabolic disorders -- 1. Hypokinetic disorders -- 1.1. Tetany -- 1.2. Catatonia -- 1.3. Parkinsonism -- 1.3.1. Alcohol withdrawal -- 1.3.2. Central pontine or extrapontine myelinolysis -- 1.3.3. Calcium and parathyroid homeostasis -- 1.3.4. Associated to uraemia and renal failure -- 1.3.5. Diabetes mellitus -- 2. Hyperkinetic disorders -- 2.1. Tremor -- 2.1.1. Kidney disorders -- 2.1.1.1. Direct consequences of renal failure -- 2.1.1.2. Consequences of electrolyte imbalance in renal failure -- 2.1.1.3. Consequences of dialysis in renal failure (manganese accumulation in the globus pallidus has been reported in pa ... -- 2.1.2. Liver failure -- 2.1.2.1. Acquired hepatocerebral degeneration (AHD) -- 2.1.2.2. Combined hepatic and neurological syndromes secondary to intake alcohol -- 2.1.3. Thyroid disorders and tremor -- 2.1.3.1. Hyperthyroidism.
|
| 505 |
8 |
|
|a 2.1.4. Wilson disease -- 2.2. Myoclonus -- 2.2.1. Acute liver failure (ALF) -- 2.2.2. Uremia -- 2.2.3. Electrolyte disturbances -- 2.2.4. Manganese poisoning (MP) -- 2.2.5. Drugs-induced myoclonus -- 2.2.6. Glucose alterations -- 2.3. Dystonia -- 2.3.1. Status dystonicus (DS) -- 2.3.2. Acute dystonic reactions in metabolic disorders -- 2.3.2.1. Biotin-thiamine-responsive basal ganglia disease (BTBGD) -- 2.3.2.2. Osmotic demyelinating syndrome (ODS) -- 2.3.2.3. Mitochondrial encephalopathy and other metabolic disorders -- 2.4. Chorea -- 2.4.1. Glycemia -- 2.4.2. Others -- 3. ATAXIA -- 3.1. Ataxia associated to vitamin deficiencies -- 3.2. Hypomagnesemia -- References -- Chapter Three: Acute psychiatric problems in movement disorders -- 1. Introduction -- 2. Parkinson�s disease (PD) -- 2.1. Psychiatric symptoms in PD -- 2.1.1. Psychosis -- 2.1.2. Impulse-control disorders and dopamine-dysregulation syndrome -- 2.1.3. Management and treatment of acute psychosis problems in PD -- 3. Dementia with Lewy bodies (DLB) -- 3.1. Psychiatric symptoms in DLB -- 3.2. Approaches to managing acute psychiatric problems in DLB -- 4. Atypical Parkinsonism -- 5. Huntington�s disease (HD) and choreas -- 5.1. Psychiatric symptoms in HD and choreas -- 5.1.1. Behavioral changes -- 5.1.2. Mood disorders -- 5.1.3. Psychosis -- 5.2. Approaches to treating acute psychiatric problems in HD and choreas -- 6. Neuroacanthocytosis -- 6.1. Psychiatric symptoms in neuroacanthocytosis -- 6.2. Strategies for managing acute psychiatric problems in neuroacanthocytosis -- 7. Tic disorders -- 7.1. Psychiatric symptoms associated with Tic disorders -- 7.2. Addressing acute psychiatric problems in Tic disorders -- 8. Dystonia -- 8.1. Psychiatric symptoms in dystonia -- 8.2. Management of acute psychiatric problems in dystonia -- 9. Myoclonus -- 9.1. Psychiatric symptoms in myoclonus.
|
| 505 |
8 |
|
|a 10. Discussion and conclusion -- References -- Chapter Four: Emergencies in deep brain stimulation -- 1. Introduction -- 2. Complications and emergencies in DBS -- 2.1. Surgery-related emergencies -- 2.1.1. Asymptomatic/symptomatic cerebrovascular accidents -- 2.1.1.1. Management -- 2.1.2. Oedema -- 2.1.2.1. Management -- 2.1.3. Seizures -- 2.1.3.1. Management -- 2.1.4. Air embolus -- 2.1.4.1. Management -- 2.1.5. Dyskinetic storm -- 2.1.5.1. Management -- 2.2. Hardware-related emergencies -- 2.2.1. Infections -- 2.2.1.1. Management -- 2.2.2. Skin erosions-without infections -- 2.2.3. Hardware failure -- 2.2.3.1. ``Twiddler�s syndrome�� -- 2.2.3.2. ``DBS withdrawal syndrome�� -- 2.2.3.3. Management -- 2.3. Medication titration-related emergencies -- 2.3.1. Dopamine withdrawal syndrome -- 2.3.1.1. Management -- 2.4. Stimulation-related emergencies -- 3. Conclusions -- References -- Chapter Five: Emergencies in pump therapies -- 1. Introduction -- 2. Intestinal levodopa infusion -- 2.1. LCIG therapy -- 3. Limitations of intestinal levodopa infusion therapy -- 3.1. Surgery -- 3.2. Pump and tube -- 3.3. Prevalence of complications -- 3.4. LECIG therapy -- 4. Limitations of subcutaneous infusion therapy -- 4.1. Apomorphine infusion -- 4.2. Possible side effects and treatment options -- 4.2.1. Neuropsychiatric side effects -- 4.3. Nausea/treatment of nausea -- 4.3.1. Postural hypotension/treatment of postural hypotension -- 4.3.2. Hemolytic anemia/treatment of hemolytic anemia -- 4.3.3. Sedation, somnolence, sleep attacks -- 4.4. Impulse control disorders (ICD) -- 4.5. Hypersexuality -- 4.6. Overdose -- 4.6.1. Foslevodopa/foscarbidopa -- 5. Conclusion -- References -- Chapter Six: Acute Parkinsonism: From viruses to non-viruses etiologies -- 1. Introduction -- 2. Acute parkinsonism with immune pathogenesis -- 2.1. Infectious parkinsonism.
|
| 505 |
8 |
|
|a 2.1.1. Classification -- 2.2. Epstein-Barr virus -- 2.3. Human immunodeficiency virus -- 2.4. Coxsackie virus -- 2.5. Flaviviruses -- 2.6. COVID-19 -- 2.7. Other infectious causes -- 2.8. Autoimmune and paraneoplastic -- 2.8.1. Anti-IgLON5 disease -- 2.8.2. Anti-Ma-2 antibodies -- 2.9. GAD-65 antibodies -- 2.10. Systemic autoimmune diseases -- 2.11. Immune checkpoint inhibitors (ICIs) and parkinsonism -- 2.12. Clinical features, pathogenesis, diagnosis and management -- 2.13. Noninfectious acute parkinsonism -- 2.13.1. Structural lesions -- 2.14. Drugs-induced Parkinsonism -- 2.15. Antipsychotics -- 2.16. Non-antipsychotic neuroleptics -- 2.17. Non-neuroleptics -- 2.18. Toxin-induced parkinsonism -- 2.19. Carbon monoxide -- 2.20. Manganese -- 2.21. MPTP -- 2.22. Rotenone -- 2.23. Psychiatric causes of acute parkinsonism -- 3. Conclusions -- References -- Chapter Seven: Acute dystonia and status dystonicus dystonia -- 1. Introduction -- 2. Acute dystonia -- 2.1. Definition -- 2.2. Epidemiology -- 2.3. Medication-induced dystonia -- 2.3.1. Antipsychotics -- 2.3.2. Antiemetics -- 2.3.3. Antiepileptics -- 2.3.4. Additionaldrugs -- 2.4. Pathophysiological mechanism -- 2.4.1. Dopaminergic receptor blockade -- 2.5. Clinical presentation -- 2.6. Differential diagnosis-ADR mimics -- 2.7. Management -- 3. Status dystonicus -- 3.1. Definition -- 3.2. Epidemiology -- 3.3. Etiology -- 3.4. Pathophysiological mechanism -- 3.5. Clinical features -- 3.6. Complications -- 3.7. Differential diagnosis -- 3.8. Management -- 4. Conclusion and summary -- References -- Chapter Eight: Emergencies in tic and choreic disorders -- 1. Emergencies in choreic disorders -- 2. Emergencies related to acute chorea/ ballism -- 2.1. Chorea related to endocrinal disorders -- 2.2. Post stroke hemichorea/ hemiballismus -- 2.3. Autoimmune/inflammatory chorea -- 2.4. Pregnancy and chorea.
|
| 505 |
8 |
|
|a 2.5. Acute chorea due to infections -- 2.6. Acute chorea related to inherited metabolic and genetic disorders -- 2.7. Drug induced chorea/ballism -- 2.7.1. Patient vignettes -- 2.7.2. Levodopa induced dyskinesia -- 2.7.3. Tardive dyskinesia -- 2.7.4. Central nervous system stimulants and chorea -- 2.7.5. Non-neuroleptic drug-induced chorea -- 2.8. DBS and ablative surgery induced chorea -- 2.9. Emergencies related to associated manifestations -- 2.10. Emergencies related to anti-chorea therapies -- 3. Emergencies in tic disorders -- 3.1. Severe exacerbation of tics and tic-related injuries -- 3.2. Self-injurious behavior -- 3.3. Emergencies secondary to exacerbations of comorbid neuropsychiatric disorders -- 3.4. Emergencies secondary to side effects of therapy -- 3.5. Emergencies observed in patients with secondary tic disorders -- 4. Conclusions -- References -- Chapter Nine: Telemedicine and digital health solutions for managing movement disorders emergencies -- 1. Introduction -- 1.1. Movement disorders emergencies -- 1.2. Impact of COVID-19 pandemic on movement disorders patients� care -- 2. Telemedicine-Current knowledge -- 2.1. Benefits and limitations of telemedicine -- 2.2. Telemedicine in remote and underserved regions -- 2.3. Telemedicine technologies and models -- 3. Telemedicine in the diagnosis of movement disorders and movement disorders emergencies -- 4. Telemedicine in the monitoring and treatment of movement disorders and movement disorders emergencies -- 5. Movement disorders patient education and satisfaction with telemedicine -- 6. Conclusions -- References -- Further reading -- Chapter Ten: Laryngeal dystonia and abductor paresis in multiple system atrophy and other conditions -- 1. Introduction -- 2. Laryngeal dystonia (LD) -- 2.1. Terminology, types, risk factors -- 2.2. Patho-neurophysiology of LD.
|
| 650 |
|
0 |
|a Movement disorders.
|
| 650 |
|
0 |
|a Emergency medicine.
|
| 650 |
|
2 |
|a Emergency Medicine
|0 (DNLM)D004635
|
| 650 |
|
6 |
|a M�edecine d'urgence.
|0 (CaQQLa)201-0017603
|
| 776 |
0 |
8 |
|i ebook version :
|z 9780443236129
|
| 776 |
0 |
8 |
|c Original
|z 0443236119
|z 9780443236112
|w (OCoLC)1381188387
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/26667878/6
|z Texto completo
|
